Email
Print
Transdermal Drug Delivery Systems Market - Forecast(2024 - 2030)
1. Transdermal Drug Delivery Systems Market - Overview
1.1 Definitions and Scope
2. Transdermal Drug Delivery Systems Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Transdermal Drug Delivery Systems Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Transdermal Drug Delivery Systems Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Transdermal Drug Delivery Systems Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Transdermal Drug Delivery Systems Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Transdermal Drug Delivery Systems Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Transdermal Drug Delivery Systems Market - By Type Of Delivery System (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Segment Analysis
8.3.1 Passive Delivery System
8.3.1.1 Matrix Delivery System
8.3.1.2 Reservoir Delivery System
8.3.2 Active Delivery System
8.3.2.1 Structure-Based Drug Delivery System
8.3.2.2 Electrically-Based Drug Delivery System
8.3.2.3 Other
9. Transdermal Drug Delivery Systems Market - By Type(Market Size -$Million / $Billion)
10. Transdermal Drug Delivery Systems - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
10.3.1 Analgesic
10.3.2 Hormone Replacement Therapy
10.3.3 Hypertension
10.3.4 Motion Sickness
10.3.5 Smoking Cessation
11. Transdermal Drug Delivery Systems- By Geography (Market Size -$Million / $Billion)
11.1 Transdermal Drug Delivery Systems Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Transdermal Drug Delivery Systems- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Transdermal Drug Delivery Systems- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Transdermal Drug Delivery Systems - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Transdermal Drug Delivery Systems - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Transdermal Drug Delivery Systems Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Transdermal Drug Delivery Systems Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Transdermal Drug Delivery Systems Market - Key Company List by Country Premium
15. Transdermal Drug Delivery Systems Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Acrux Limited
15.3 Bayer Ag
15.4 Boehringer Ingelheim Gmbh
15.5 Bristol-Myers Squibb Company
15.6 Echo Therapeutics, Inc
15.7 Endo Pharmaceutical Inc
15.8 Glaxosmithkline Plc
15.9 Johnson Johnson
15.10 Mylan N V
15.11 Novartis Ag
15.12 Company 12
15.13 Company 13 & More
16.1 Abbreviations
16.2 Sources
17. Transdermal Drug Delivery Systems Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. Transdermal Drug Delivery Systems Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Transdermal Drug Delivery Systems Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Transdermal Drug Delivery Systems Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Transdermal Drug Delivery Systems Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Transdermal Drug Delivery Systems Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Transdermal Drug Delivery Systems Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Transdermal Drug Delivery Systems Market - By Type Of Delivery System (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Segment Analysis
8.3.1 Passive Delivery System
8.3.1.1 Matrix Delivery System
8.3.1.2 Reservoir Delivery System
8.3.2 Active Delivery System
8.3.2.1 Structure-Based Drug Delivery System
8.3.2.2 Electrically-Based Drug Delivery System
8.3.2.3 Other
9. Transdermal Drug Delivery Systems Market - By Type(Market Size -$Million / $Billion)
10. Transdermal Drug Delivery Systems - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
10.3.1 Analgesic
10.3.2 Hormone Replacement Therapy
10.3.3 Hypertension
10.3.4 Motion Sickness
10.3.5 Smoking Cessation
11. Transdermal Drug Delivery Systems- By Geography (Market Size -$Million / $Billion)
11.1 Transdermal Drug Delivery Systems Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Transdermal Drug Delivery Systems- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Transdermal Drug Delivery Systems- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Transdermal Drug Delivery Systems - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Transdermal Drug Delivery Systems - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Transdermal Drug Delivery Systems Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Transdermal Drug Delivery Systems Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Transdermal Drug Delivery Systems Market - Key Company List by Country Premium
15. Transdermal Drug Delivery Systems Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Acrux Limited
15.3 Bayer Ag
15.4 Boehringer Ingelheim Gmbh
15.5 Bristol-Myers Squibb Company
15.6 Echo Therapeutics, Inc
15.7 Endo Pharmaceutical Inc
15.8 Glaxosmithkline Plc
15.9 Johnson Johnson
15.10 Mylan N V
15.11 Novartis Ag
15.12 Company 12
15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Transdermal Drug Delivery Systems Market - Appendix16.1 Abbreviations
16.2 Sources
17. Transdermal Drug Delivery Systems Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Transdermal Drug Delivery System Market, By Type Of Delivery System Market 2023-2030 ($M)1.1 Passive Delivery System Market 2023-2030 ($M) - Global Industry Research
1.1.1 Matrix Delivery System Market 2023-2030 ($M)
1.1.2 Reservoir Delivery System Market 2023-2030 ($M)
1.2 Active Delivery System Market 2023-2030 ($M) - Global Industry Research
1.2.1 Structure-Based Drug Delivery System Market 2023-2030 ($M)
1.2.2 Electrically-Based Drug Delivery System Market 2023-2030 ($M)
2.Global Transdermal Drug Delivery System Market, By Type Of Delivery System Market 2023-2030 (Volume/Units)
2.1 Passive Delivery System Market 2023-2030 (Volume/Units) - Global Industry Research
2.1.1 Matrix Delivery System Market 2023-2030 (Volume/Units)
2.1.2 Reservoir Delivery System Market 2023-2030 (Volume/Units)
2.2 Active Delivery System Market 2023-2030 (Volume/Units) - Global Industry Research
2.2.1 Structure-Based Drug Delivery System Market 2023-2030 (Volume/Units)
2.2.2 Electrically-Based Drug Delivery System Market 2023-2030 (Volume/Units)
3.North America Transdermal Drug Delivery System Market, By Type Of Delivery System Market 2023-2030 ($M)
3.1 Passive Delivery System Market 2023-2030 ($M) - Regional Industry Research
3.1.1 Matrix Delivery System Market 2023-2030 ($M)
3.1.2 Reservoir Delivery System Market 2023-2030 ($M)
3.2 Active Delivery System Market 2023-2030 ($M) - Regional Industry Research
3.2.1 Structure-Based Drug Delivery System Market 2023-2030 ($M)
3.2.2 Electrically-Based Drug Delivery System Market 2023-2030 ($M)
4.South America Transdermal Drug Delivery System Market, By Type Of Delivery System Market 2023-2030 ($M)
4.1 Passive Delivery System Market 2023-2030 ($M) - Regional Industry Research
4.1.1 Matrix Delivery System Market 2023-2030 ($M)
4.1.2 Reservoir Delivery System Market 2023-2030 ($M)
4.2 Active Delivery System Market 2023-2030 ($M) - Regional Industry Research
4.2.1 Structure-Based Drug Delivery System Market 2023-2030 ($M)
4.2.2 Electrically-Based Drug Delivery System Market 2023-2030 ($M)
5.Europe Transdermal Drug Delivery System Market, By Type Of Delivery System Market 2023-2030 ($M)
5.1 Passive Delivery System Market 2023-2030 ($M) - Regional Industry Research
5.1.1 Matrix Delivery System Market 2023-2030 ($M)
5.1.2 Reservoir Delivery System Market 2023-2030 ($M)
5.2 Active Delivery System Market 2023-2030 ($M) - Regional Industry Research
5.2.1 Structure-Based Drug Delivery System Market 2023-2030 ($M)
5.2.2 Electrically-Based Drug Delivery System Market 2023-2030 ($M)
6.APAC Transdermal Drug Delivery System Market, By Type Of Delivery System Market 2023-2030 ($M)
6.1 Passive Delivery System Market 2023-2030 ($M) - Regional Industry Research
6.1.1 Matrix Delivery System Market 2023-2030 ($M)
6.1.2 Reservoir Delivery System Market 2023-2030 ($M)
6.2 Active Delivery System Market 2023-2030 ($M) - Regional Industry Research
6.2.1 Structure-Based Drug Delivery System Market 2023-2030 ($M)
6.2.2 Electrically-Based Drug Delivery System Market 2023-2030 ($M)
7.MENA Transdermal Drug Delivery System Market, By Type Of Delivery System Market 2023-2030 ($M)
7.1 Passive Delivery System Market 2023-2030 ($M) - Regional Industry Research
7.1.1 Matrix Delivery System Market 2023-2030 ($M)
7.1.2 Reservoir Delivery System Market 2023-2030 ($M)
7.2 Active Delivery System Market 2023-2030 ($M) - Regional Industry Research
7.2.1 Structure-Based Drug Delivery System Market 2023-2030 ($M)
7.2.2 Electrically-Based Drug Delivery System Market 2023-2030 ($M)
LIST OF FIGURES
1.US Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)2.Canada Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
3.Mexico Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
4.Brazil Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
5.Argentina Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
6.Peru Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
7.Colombia Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
8.Chile Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
9.Rest of South America Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
10.UK Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
11.Germany Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
12.France Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
13.Italy Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
14.Spain Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
15.Rest of Europe Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
16.China Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
17.India Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
18.Japan Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
19.South Korea Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
20.South Africa Transdermal Drug Delivery Systems Market Revenue, 2023-2030 ($M)
21.North America Transdermal Drug Delivery Systems By Application
22.South America Transdermal Drug Delivery Systems By Application
23.Europe Transdermal Drug Delivery Systems By Application
24.APAC Transdermal Drug Delivery Systems By Application
25.MENA Transdermal Drug Delivery Systems By Application
26.Acrux Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Bayer Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Boehringer Ingelheim Gmbh, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Bristol-Myers Squibb Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Echo Therapeutics, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Endo Pharmaceutical Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Glaxosmithkline Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Johnson Johnson, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Mylan N V, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Novartis Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)